Medical Research
(H30)
IRS Verified
DX Registered
990 on File
MASSACHUSETTS PROSTATE CANCER COALITION INC
Financial strength (30%)
85/100
Reliability (20%)
55/100
Effectiveness (25%)
73/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$165K
Total Revenue
$178K
Total Expenses
$127K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
78.1%
Fundraising Efficiency
N/A
Operating Reserve
8.54x
Liability-to-Asset
2.8%
Revenue Diversification
98.4%
Compared with Peers
FY 2024
Compared with 726 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
78.1% | 84.5% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
8.5 mo | 13.4 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
2.8% | 0.4% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
98.4% | 93.3% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
3.7% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
21.9% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-7.8% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $165K | $178K | $127K | 78.1% | — |
| 2023 | $159K | $146K | $140K | 76.1% | — |
| 2022 | $148K | $150K | $126K | 61.8% | — |
| 2021 | $380K | $171K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.